Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04690075
Other study ID # DFiber-CD-2020-2021
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 24, 2020
Est. completion date June 30, 2021

Study information

Verified date January 2021
Source Peking Union Medical College Hospital
Contact Kang Yu, M.D.
Phone +86 01-69155550
Email yuk1997@sina.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The prevalence of chronic disease is increasing rapidly in China. Medical nutritional therapy (MNT) is essential for the prevention and control of chronic diseases. For example, dietary fiber plays an important role in chronic disease management. Evidence suggests that increasing fiber intake can decrease the risk of chronic diseases, such as overweight/obesity, hyperlipidemia, hyperglycemia, GI diseases, etc. However, according to the nation-wide survey, the dietary fiber intake of Chinese people shows a downward trend in recent years, and the relationship between dietary fiber and metabolism of chronic patients is still controversial. So, this study aims to explore the effects of dietary fiber on metabolism, inflammatory factors and nutritional status among patients with chronic diseases, so as to provide reference for proper nutrition intervention towards chronic disease.


Description:

Investigators plan to recruit potential participants in hospital clinics using posters. An anticipated total of 120 patients with chronic diseases (including overweight, obesity, hyperlipemia, hyperglycemia, etc) will be randomized to receive oat beta-glucans (study group) or routine nutrition management (control group) respectively. The outcome parameters, including weight, blood glucose level, blood fat level, etc, will be measured and compared over a 12-week intervention period. Intention-to-treat analysis (ITT) and per-protocol analysis (PP) will be conducted in statistical analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date June 30, 2021
Est. primary completion date April 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Age 18-70y - Be diagnosed with obesity, hyperlipemia or hyperglycemia - Fully understood and voluntarily signed the informed consent Exclusion Criteria: - Secondary hyperlipidemia or hyperglycemia - Multiple organ failure - Allergic or intolerant to dietary fiber(dietary supplement) - Have gastrointestinal diseases - Have a history of abdominal diseases - Experienced intra-abdominal surgery - Pregnant and lactating women

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Nutrition Management and Dietary Fiber
Routine nutrition management and dietary fiber supplements based on recommendation for 12 weeks.
Nutrition Management
Routine nutrition management for 12 weeks.

Locations

Country Name City State
China Peking Union Medical College Hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking Union Medical College Hospital

Country where clinical trial is conducted

China, 

References & Publications (6)

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27. Erratum in: Lancet. 2005 Oct 15-21;366(9494):1358. Lancet. 2008 Jun 21;371(9630):2084. — View Citation

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10. — View Citation

Nutrition recommendations and principles for people with diabetes mellitus. American Diabetes Association. J Fla Med Assoc. 1998 Aug;85(2):25-9. — View Citation

Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154. doi: 10.2337/dc16-2042. Review. — View Citation

Ren J, Grundy SM, Liu J, Wang W, Wang M, Sun J, Liu J, Li Y, Wu Z, Zhao D. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis. 2010 Jul;211(1):327-32. doi: 10.1016/j.atherosclerosis.2010.02.020. Epub 2010 Feb 21. — View Citation

Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, Zhou M, Tang X, Hu Y, Wang L. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017 Jun 27;317(24):2515-2523. doi: 10.1001/jama.2017.7596. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change of total cholesterol (TC) level Total cholesterol (TC) level obtained from laboratory test baseline, 12 weeks
Primary Change of low density lipoprotein (LDL) cholesterol level Low density lipoprotein (LDL) cholesterol level obtained from laboratory test baseline, 12 weeks
Secondary Change of interleukin-6 (IL-6) level Interleukin-6 (IL-6) level obtained from laboratory test baseline, 12 weeks
Secondary Change of tumor necrosis factor-alpha level Change of tumor necrosis factor-alpha level obtained from laboratory test baseline, 12 weeks
Secondary Change of triglyceride (TG) level Change of triglyceride (TG) level obtained from laboratory test baseline, 12 weeks
Secondary Change of high density lipoprotein (HDL) cholesterol level Change of high density lipoprotein (HDL) cholesterol level obtained from laboratory test baseline, 12 weeks
Secondary Change of fasting blood glucose (FBG) level Change of fasting blood glucose (FBG) level obtained from laboratory test baseline, 12 weeks
Secondary Change of 2 hours postprandial blood glucose level Change of 2 hours postprandial blood glucose level obtained from laboratory test baseline, 12 weeks
Secondary Change of hemoglobin level Change of hemoglobin level obtained from laboratory test baseline, 12 weeks
Secondary Change of total body fat level Change of total body fat level obtained from bioelectrical impedance analysis baseline, 12 weeks
Secondary Change of Percent of body fat (PBF) level Change of percent of body fat (PBF) level obtained from bioelectrical impedance analysis baseline, 12 weeks
Secondary Change of visceral fat area (VFA) level Change of visceral fat area (VFA) level obtained from bioelectrical impedance analysis baseline, 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Recruiting NCT06058754 - Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT Trial) N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05558085 - Biomarker Cost-Benefit Analysis of EFNEP N/A
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Not yet recruiting NCT05622422 - A Chronic Disease Self Care Management Pilot Study N/A
Not yet recruiting NCT06016101 - Usefulness of the Medissimo Nurse Application for Supporting Medication Compliance in Elderly People With Chronic Polypathologies
Not yet recruiting NCT04954209 - Comparative Study in Long-term Commitment to Physical Activity After Two Different Resumption Programs
Not yet recruiting NCT04090593 - Chronic Disease Mobile Educational Experience N/A
Not yet recruiting NCT03628963 - Optimizing Patient Usability Experience for Chronic Care N/A
Completed NCT02390570 - Incorporating Patient Capacity Into the Clinical Landscape N/A
Completed NCT02072941 - Preparing Spanish-speaking Older Adults for Advance Care Planning and Medical Decision Making (PREPARE) N/A
Completed NCT02017262 - Group Self-Management of Depression and Medical Illness N/A
Completed NCT01933789 - Improving Communication About Serious Illness N/A
Completed NCT02292940 - Consumer Health IT Tools: Impact on Experience, Access, and Outcomes for Patients With Complex Chronic Conditions
Terminated NCT02115971 - Jumping Exercises Approach in Individuals With Chronic Ankle Instability N/A
Completed NCT02307929 - Evaluation of Quality of Care - Nurse Allied Health Clinic Programme, HA N/A
Completed NCT01458184 - Study of PhoneCare System to Treat Patients With Chronic Diseases N/A
Completed NCT00380536 - Medical Self-Management for Improving Health Behavior Among Individuals in Community Mental Health Settings N/A
Completed NCT00333710 - Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD N/A